Beacon Capital Management LLC (Tennessee)’s iShares Biotechnology ETF IBB Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-387	Closed	-$49K	–	528
2025 Q2	$49K	Hold	387	–	–	0.01%	336
2025 Q1	$49.5K	Sell	387 -12	-3%	-$1.63K	0.01%	318
2024 Q4	$52.7K	Hold	399	–	–	0.01%	293
2024 Q3	$58K	Hold	399	–	–	0.01%	299
2024 Q2	$54.7K	Hold	399	–	–	0.01%	273
2024 Q1	$54.7K	Buy	399 +1	+0.3%	+$137	0.01%	279
2023 Q4	$48.6K	Hold	398	–	–	0.01%	228
2023 Q3	$50.5K	Hold	398	–	–	0.01%	246
2023 Q2	$50.5K	Hold	398	–	–	0.01%	246
2023 Q1	$51.4K	Sell	398 -9	-2%	-$1.18K	0.02%	212
2022 Q4	$53.5K	Buy	407 +27	+7%	+$3.49K	0.02%	210
2022 Q3	$44K	Hold	380	–	–	0.01%	224
2022 Q2	$50K	Hold	380	–	–	0.01%	244
2022 Q1	$50K	Buy	+380	New	+$49.5K	0.01%	244

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s IBB Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 387 shares — an estimated $49K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in IBB in Q1 2022 and held it in 14 quarters. The position peaked at $58K in Q3 2024. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

Beacon Capital Management LLC (Tennessee) reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Beacon Capital Management LLC (Tennessee) sold 387 iShares Biotechnology ETF shares in Q3 2025, an estimated $49K.
Beacon Capital Management LLC (Tennessee) first reported a position in iShares Biotechnology ETF in Q1 2022 and held it in 14 quarters.
Beacon Capital Management LLC (Tennessee)'s iShares Biotechnology ETF position peaked at $58K in Q3 2024.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.